IN RE GENERIC PHARMA. PRICING ANTITRUST LITIG.

MDL 2724 16-MD-2724.

490 F.Supp.3d 901 (2020)

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION. This Document Relates to: All Actions.

United States District Court, E.D. Pennsylvania.

Filed September 28, 2020.


ORDER

AND NOW, this 28th day of September 2020, upon de novo review of the Amended Report and Recommendation of Special Discovery Master for ESI Daniel L. Regard Relating to Global Search Term Modifications Requested by Sandoz [MDL Doc. No. 1416], and the briefing of the parties in connection therewith...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases